Drug Profile
Paclitaxel lipid nanocapsules - Carlina Technologies
Alternative Names: SOLUDOTS-PTXLatest Information Update: 27 Jul 2023
Price :
$50
*
At a glance
- Originator Carlina Technologies
- Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Mitosis inhibitors; Platelet-derived growth factor inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Non-small cell lung cancer; Ovarian cancer
Most Recent Events
- 27 Jul 2023 Discontinued - Preclinical for Non-small cell lung cancer in France (IV)
- 27 Jul 2023 Discontinued - Preclinical for Ovarian cancer in France (IV)
- 28 Dec 2018 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in France (IV, Injection)